Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(20%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
20%
Ph phase_2
1
20%
Ph phase_4
3
60%

Phase Distribution

0

Early Stage

1

Mid Stage

3

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
1(20.0%)
Phase 4Post-market surveillance
3(60.0%)
N/ANon-phased studies
1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(2)
Other(2)

Detailed Status

Completed2
unknown2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (20.0%)
Phase 43 (60.0%)
N/A1 (20.0%)

Trials by Status

completed240%
unknown240%
recruiting120%

Recent Activity

1 active trials
Showing 5 of 5
recruitingphase_2

Metformin for the Treatment of mCRC Patients Undergoing FOLFIRI Plus Target Therapy

NCT06826092
unknownphase_4

Treating Obese PCOS Patients With LSG vs. Met

NCT04508634
unknownnot_applicable

Research on Risk Factors and Interventions of Polycystic Ovary Syndrome Complicated With Depression and Anxiety

NCT04984070
completedphase_4

Vildagliptin in Older Adults With Diabetes and Mild Cognitive Impairment

NCT03819127
completedphase_4

Metformin Versus Vildagliptin for Diabetic Hypertensive Patients

NCT03253562

Clinical Trials (5)

Showing 5 of 5 trials
NCT06826092Phase 2

Metformin for the Treatment of mCRC Patients Undergoing FOLFIRI Plus Target Therapy

Recruiting
NCT04508634Phase 4

Treating Obese PCOS Patients With LSG vs. Met

Unknown
NCT04984070Not Applicable

Research on Risk Factors and Interventions of Polycystic Ovary Syndrome Complicated With Depression and Anxiety

Unknown
NCT03819127Phase 4

Vildagliptin in Older Adults With Diabetes and Mild Cognitive Impairment

Completed
NCT03253562Phase 4

Metformin Versus Vildagliptin for Diabetic Hypertensive Patients

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5